Jana Medical Company (TADAWUL:9616)

Jana Medical Company Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	0.92	1.71	1.43
Cash & Short-Term Investments	0.92	1.71	1.43
Cash Growth	-	20.03%	-
Accounts Receivable	78.95	68.17	40.47
Other Receivables	3.64	0.44	4.94
Receivables	82.59	68.62	45.41
Inventory	0.76	1.6	10.34
Prepaid Expenses	0.24	0.63	0.3
Other Current Assets	2.49	3.89	3.98
Total Current Assets	87	76.45	61.46
Property, Plant & Equipment	0.95	1.35	1.72
Other Intangible Assets	0.08	0.08	0
Total Assets	88.03	77.88	63.18
Accounts Payable	11.51	3.36	3.29
Accrued Expenses	2.33	1.74	2.12
Short-Term Debt	-	4.88	-
Current Portion of Long-Term Debt	28.3	22.47	22.03
Current Portion of Leases	0.45	0.24	0.35
Current Income Taxes Payable	1.39	1.13	0.34
Other Current Liabilities	1.3	1.05	0.31
Total Current Liabilities	45.32	34.86	28.45
Long-Term Debt	8.38	4.98	2.02
Long-Term Leases	0.17	0.74	1.01
Total Liabilities	55.12	41.62	32.57
Common Stock	25.7	25.7	25.7
Retained Earnings	7.22	10.56	4.91
Shareholders' Equity	32.92	36.26	30.61
Total Liabilities & Equity	88.03	77.88	63.18
Total Debt	37.3	33.31	25.41
Net Cash (Debt)	-36.38	-31.6	-23.98
Net Cash Per Share	-14.16	-12.29	-11.93
Filing Date Shares Outstanding	3.21	3.21	2.01
Total Common Shares Outstanding	3.21	3.21	2.01
Working Capital	41.68	41.58	33.01
Book Value Per Share	10.25	11.29	15.23
Tangible Book Value	32.84	36.18	30.61
Tangible Book Value Per Share	10.22	11.26	15.22
Machinery	0.63	0.63	0.48
Leasehold Improvements	0.1	0.1	0.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.